ERCC4, ERCC excision repair 4, endonuclease catalytic subunit, 2072
N. diseases: 325; N. variants: 33
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phenotype | Anatomical Abnormality | 22 | 0.100 | None | 0 | ||||||||||
|
group | Neoplasms; Eye Diseases | Neoplastic Process | 24 | 0.100 | None | 0 | |||||||||
|
disease | Hemic and Lymphatic Diseases | Disease or Syndrome | 24 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 24 | 0.100 | None | 0 | ||||||||||
|
disease | Neoplastic Process | 25 | 0.010 | None | 1.000 | 1 | 2014 | 2014 | |||||||
|
disease | Musculoskeletal Diseases; Nervous System Diseases; Endocrine System Diseases | Congenital Abnormality | 25 | 9 | 0.300 | strong | 0 | ||||||||
|
phenotype | Finding | 25 | 0.100 | None | 0 | ||||||||||
|
phenotype | Pathological Conditions, Signs and Symptoms | Cell Component | 26 | 0.300 | None | 1.000 | 2 | 2011 | 2013 | ||||||
|
phenotype | Pathological Conditions, Signs and Symptoms | Cell Component | 26 | 0.300 | None | 1.000 | 2 | 2011 | 2013 | ||||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | Finding | 26 | 8 | 0.100 | None | 0 | ||||||||
|
disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases | Anatomical Abnormality | 29 | 1 | 0.100 | None | 0 | ||||||||
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | Neoplastic Process | 29 | 0.300 | None | 0 | |||||||||
|
disease | Anatomical Abnormality | 29 | 1 | 0.100 | None | 0 | |||||||||
|
phenotype | Male Urogenital Diseases | Finding | 30 | 0.100 | None | 0 | |||||||||
|
disease | Anatomical Abnormality | 30 | 0.100 | None | 0 | ||||||||||
|
disease | Anatomical Abnormality | 32 | 0.100 | None | 0 | ||||||||||
|
disease | Anatomical Abnormality | 33 | 1 | 0.100 | None | 0 | |||||||||
|
group | Neoplasms | Neoplastic Process | 34 | 0.300 | None | 1.000 | 1 | 2010 | 2010 | ||||||
|
phenotype | Finding | 34 | 0.300 | strong | 1.000 | 1 | 2013 | 2013 | |||||||
|
phenotype | Cell or Molecular Dysfunction | 34 | 1 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 35 | 1 | 0.100 | None | 0 | |||||||||
|
phenotype | Finding | 40 | 1 | 0.100 | None | 0 | |||||||||
|
disease | Anatomical Abnormality | 40 | 0.100 | None | 0 | ||||||||||
|
phenotype | Finding | 40 | 1 | 0.100 | None | 0 | |||||||||
|
disease | Neoplastic Process | 41 | 0.010 | None | 1.000 | 1 | 2019 | 2019 |